A new DRUG TRIAL SNAPSHOT FOR UPTRAVI is now available. UPTRAVI is a drug used for the treatment of adults with pulmonary arterial hypertension. Pulmonary arterial hypertension (PAH) is a rare, chronic, and progressive lung disease in which there is abnormally high blood pressure in the pulmonary artery, the blood vessel that carries blood from the heart to the lungs. PAH can lead to death or the need for transplantation.
Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.
See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.
.png)
No hay comentarios:
Publicar un comentario